Constipation is often overlooked in cancer care, yet treatment side effects, dehydration and stress make it common. An expert breaks down symptoms, causes, complications and practical relief tips.
T-DXd plus pertuzumab improved quality-of-life outcomes, with fewer skin and mucosal symptoms but more gastrointestinal issues compared to the standard regimen. Both treatment arms showed similar pain ...
A new study suggests popular GLP-1 drugs, like Ozempic and Zepbound, may not lower cancer risk as some had hoped.
Pfizer has rolled out detailed trial data suggesting Tukysa could be part of a new first-line treatment to delay the progression of HER2-positive breast cancer. | Pfizer has rolled out detailed trial ...
Presentation Title: The ADELA study: A Double-blind, Placebo-controlled, Randomized Phase 3 Trial of Elacestrant (ELA)+ Everolimus (EVE) Versus ELA + Placebo (PBO) in ER+/HER2-Advanced Breast Cancer ...
FDA approves pembrolizumab and enfortumab vedotin for neoadjuvant and adjuvant treatment of cisplatin-ineligible muscle-invasive bladder cancer.
Sportschosun on MSN
Soonchunhyang University Bucheon Hospital, Completion of the Diet Exhibition for Cancer Patients...P...
Soon Chun Hyang University Bucheon Hospital (Hospital Director Moon Jong-ho) held the '2025 Cancer Patients' Diet Exhibition' ...
WSW, NY, December 10th, 2025, FinanceWireThe first use of Alpha DaRT in a human brain tumor sets a new clinical precedent ...
Reports show lung cancer mortality in Ohio is decreasing, but the disease remains the leading cause of cancer deaths in ...
The MHRA has approved inavolisib for adults with PIK3CA-mutated HR+/HER2– breast cancer, offering a new targeted first-line ...
In May 2025, former President Joe Biden's health took a serious turn when his medical team revealed a diagnosis of aggressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback